首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Reply: Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy Reply
【24h】

Reply: Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy Reply

机译:回答:他克莫司单药与三联疗法的随机试验中,肝移植后复发性丙型肝炎病毒的结果

获取原文
获取原文并翻译 | 示例
           

摘要

We thank Dr. Cross for his useful comments1 based on our work.2 In our study, we demonstrated that long-term maintenance immunosuppression with azathioprine and tacrolimus along with shorter term prednisolone [triple therapy (TT)] resulted in a slower onset of histologically severe fibrosis and portal hypertension in recipients with hepatitis C virus (HCV) and cirrhosis in comparison with tacrolimus monotherapy (MT).
机译:我们感谢Cross博士根据我们的工作提出的有益评论1。2在我们的研究中,我们证明了硫唑嘌呤和他克莫司的长期维持性免疫抑制以及短期泼尼松龙[三联疗法(TT)]导致组织学发作缓慢与他克莫司单药治疗(MT)相比,患有丙型肝炎病毒(HCV)和肝硬化的患者出现严重的纤维化和门脉高压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号